Centralized Imaging Review in Multicenter Clinical Trials: Enabling Consistent and Reliable Endpoint Evaluation
Medical imaging has become an essential component of modern clinical trials, supporting efficacy assessments, safety evaluations, and regulatory decision-making across therapeutic areas such as oncology, ophthalmology, Gastroenterology and musculoskeletal disorders.…
Six Months of Pharmacovigilance Excellence in 2026: Delivering Global Drug Safety with Quality and Compliance
Pharmacovigilance Beyond Compliance Pharmacovigilance is no longer limited to meeting regulatory requirements. It has become a strategic function that enables sponsors to identify safety signals early, maintain global compliance, and…
FDA Releases Revised Draft Guidance on Master Protocols for Drug and Biological Product Development
The FDA's revised draft guidance on Master Protocols for Drug and Biological Product Development introduces updated recommendations for umbrella, basket, and platform trials, reflecting the growing role of innovative clinical…
Multicentre Paediatric Acceptability Study for Cyclophosphamide Powder
From Study Execution to EMA Success A Global Phase III Program for Ranibizumab – Ophthalmic Biosimilar
From Research to Real-World Impact: Lambda’s Journey on International Clinical Trials Day
Every year on 20 May, the global clinical research community observes International Clinical Trials Day, a moment to recognize the scientific progress, collaboration, and patient participation that make medical advancement…
Unannounced US FDA inspection concludes with Zero 483 at Lambda’s Ahmedabad Facility
NEWS
Biotherapeutics & Large Molecule Bioanalytical Services
Lambda Therapeutic Research provides comprehensive bioanalytical services for biotherapeutics and large molecules, supporting biologic and biosimilar programs across preclinical and clinical development. With extensive experience in large molecule bioanalysis, we…
Transdermal and Topical Products: Early Phase BA BE Study Capabilities
Lambda conducts early phase BA/BE studies for transdermal and topical products with a focus on pharmacokinetics, adhesion performance, and skin safety. Experience spans multiple molecules and dosage forms, supported by controlled application techniques and consistent study execution.
- 1
- 2
- 3
- 4
- …
- 14
- Go to the next page